News

Palantir Has a Hand in NIH’s Most Ambitious Health Initiative

By Julia Métraux, Mother Jones [cites CGS' Katie Hasson] | 07.07.2026

During his 2015 State of the Union address, then-President Barack Obama announced what he promised would be an ambitious public health project. “Tonight, I’m launching a new Precision Medicine Initiative to bring us closer to curing diseases like cancer and diabetes...

U.S. Federal

The Measured Listener

By Daniel Shanahan, Los Angeles Review of Books | 05.31.2026

This is the 15th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. You can read the first part here. The series...

U.S. States

These companies help parents try to pick their babies' traits. Experts are wary

By Rob Stein, NPR [cites CGS' Katie Hasson] | 05.06.2026

Justin Schleede reaches onto a black lab bench to pick up a tray of small plastic tubes.

"These are saliva...

Genetic Selection

The start-ups dreaming of creating genetically modified babies

By Alexandre Piquard, Le Monde [cites CGS' Katie Hasson] | 05.22.2026

"If proven to be safe, we believe preventive gene editing could be one of the most important health technologies of...

U.S. Federal

New York State Set to Add All Convict DNA to Its Database

By John Eligon and Thomas Kaplan, New York Times | 03.14.2012

ALBANY — New York is poised to establish one of the most expansive DNA databases in the nation, requiring people...

Genomics

FDA Receives Complaint About Houston Company that Stored Gov. Perry's Stem Cells

By Todd Ackerman, Houston Chronicle | 03.14.2012
The U.S. Food and Drug Administration has received a complaint alleging the Houston company involved in Gov. Rick Perry's...
Bioethics

Environmental Groups Call for Tighter Regulation of ‘Extreme Genetic Engineering’

By Brian Vastag, Washington Post | 03.13.2012

Genetically engineered microbes that might one day churn out biofuels, clean up toxic waste or generate new medicines need to...

Genomics

Celltex Muscles Ethics Professor For Contacting FDA

By Ed Silverman , Pharmalot | 03.12.2012
Over the past month, a controversy erupted involving a stem cell company called Celltex Therapeutics and a newly hired executive...
Bioethics

Canada’s Murky Legal World of Surrogate-Consultants and Human-Egg Buyers

By Tom Blackwell, National Post | 03.09.2012

Struggling to make ends meet as a university English major, Elizabeth could not help but notice the online classified ad...

Reproductive Justice, Health & Rights

Gene Therapists Ask to be Released From the RAC

By Jocelyn Kaise, Science Insider | 03.09.2012
The main U.S. professional society representing gene therapists argued this week that clinical trials in their maturing field should no...
Genomics

'Personalized Medicine' Hits a Bump

By Ron Winslow, The Wall Street Journal | 03.07.2012
A tumor's genetic makeup can vary significantly even within the same tumor sample, researchers said, a finding that poses new...
Genomics

The Case Against DNA

By William Langley, The Telegraph | 03.06.2012

Sitting in the dock of a brightly lit courtroom, David Butler cocks his head to one side as he listens...

Genomics